Inspire Your Thinking
Innovation Lab events are exclusive conferences for marketers of drugs in the rare disease space to learn and share best practices in developing relationships and communication strategies across the brand lifecycle.
In the rare disease space there are few competing brands, which creates a unique opportunity to share best practices. We all face the same challenges—how to determine optimum price, how to assess market size, how to best engage the patient community—and there is great benefit to sharing our collective experiences and knowledge. This is the idea behind our industry-only Innovation Lab events.
More than passive "sit and listen" sessions, these workshops are engaging, interactive events from which attendees emerge smarter and armed with real marketing solutions for their company or brand(s).
Innovation Lab events are by invitation only. If you're interested in attending our next Innovation Lab event, please register now!
Marketers of orphan drugs and rare disease therapies convened at the 7th Annual Innovation Lab in Boston, MA. The event provided a forum for participants to discern, discuss, and debate key issues in the industry, including patient community engagement, communication strategies across the brand lifecycle, value propositions and pricing models, and patient insights perspectives.
Spring 2013 » The Great Orphan Drug Debate: Washington, DC
At Charlie Palmer Steak Restaurant in Washington, DC, when the cherry blossoms were in bloom, key stakeholders of orphan drugs for rare and ultra-rare diseases gathered for the Great Orphan Drug Debate of 2013, sponsored by Compass Healthcare Marketers and Medical Marketing Economics, LLC (MME). The Great Debate is an annual event that provides the opportunity for industry leaders to hear opposing views on pressing issues and engage in a lively discussion. This year’s debates focused on value propositions.
Since last fall's edition of the Innovation Lab series at Cavallo Point in San Francisco was such a success, Compass Healthcare Marketers decided to head back there for the Fall 2012 installment. This year's meeting focused on how to provide and receive the right amount of value from each patient you target with your orphan brand. Maximizing patient value isn't such a point of emphasis in more prevalent disease states and chronic-care categories; when you are dealing with such small patient populations there really is no other choice. The spirited and lively discussion at this year's meeting displayed just how important this topic is to the rare disease and orphan drug community. The result of that enthusiasm was another successful Innovation Lab workshop.
© 2014 Compass Healthcare Marketers®. All rights reserved.